Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Philip F. Berg

Senior Healthcare Attorney

Philip F. Berg

Senior Healthcare Attorney

Phil Berg helps healthcare providers and companies navigate transactions, compliance issues and operational contracts. Phil has significant experience working with hospitals, ambulatory surgery centers (ASC), joint ventures, physician practices, and other healthcare companies. Phil has represented some of the largest ASC companies in the country, as well as start-ups, on issues including acquisitions, operational issues, Medicare matters, and complex regulatory analysis.

His practice involves:

  • Operational contracts – Drafting physician employment agreements, laboratory agreements, and complex multi-facility service line agreements with national vendors. 
  • Transactions – Representing companies in acquisitions of physician practices by hospitals, acquisitions of ambulatory surgery centers by national management companies, mergers of hospital companies, joint ventures with physicians and healthcare companies.
  • Complex regulatory analysis – Providing analysis of Federal Stark law issues, Federal Anti-Kickback Statute issues, state laws, licensure, Certificate of Need and other healthcare issues that may impact deals, contracts and compliance.
  • Corporate practice of medicine issues – Providing analysis and corporate guidance for practice management companies, such as dental, medical and hospitalist. 

Memberships

American Health Lawyers Association (AHLA)

Christian Legal Society (2000-2004)

International Law Society (2000)

Nashville Bar Association — Pro Bono Program (2000)

Representative Experience

View More

Publications

View More

Accolades

Vanderbilt Law Review — Associate Editor (2003-2004)

Vanderbilt Scholastic Excellence Award — Law & Finance of Mergers & Acquisitions (2003)

Beta Gamma Sigma

Franklin & White Best Brief Award (2001)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.